Hospital variation in responses to safety warnings about power morcellation in hysterectomy
- PMID: 33359176
- PMCID: PMC8180513
- DOI: 10.1016/j.ajog.2020.12.1207
Hospital variation in responses to safety warnings about power morcellation in hysterectomy
Abstract
Background: Safety warnings about power morcellation in 2014 considerably changed hysterectomy practice, especially for laparoscopic supracervical hysterectomy that typically requires morcellation to remove the corpus uteri while preserving the cervix. Hospitals might vary in how they respond to safety warnings and altered hysterectomy procedures to avoid use of power morcellation. However, there has been little data on how hospitals differ in their practice changes.
Objective: This study aimed to examine whether hospitals varied in their use of laparoscopic supracervical hysterectomy after safety warnings about power morcellation and compare the risk of surgical complications at hospitals that had different response trajectories in use of laparoscopic supracervical hysterectomy.
Study design: This was a retrospective analysis of data from the New York Statewide Planning and Research Cooperative System and the State Inpatient Databases and State Ambulatory Surgery and Services Databases from 14 other states. We identified women aged ≥18 years undergoing hysterectomy for benign indications in the hospital inpatient and outpatient settings from October 1, 2013 to September 30, 2015. We calculated a risk-adjusted utilization rate of laparoscopic supracervical hysterectomy for each hospital in each calendar quarter after accounting for patient clinical risk factors. Applying a growth mixture modeling approach, we identified distinct groups of hospitals that exhibited different trajectories of using laparoscopic supracervical hysterectomy over time. Within each trajectory group, we compared patients' risk of surgical complications in the prewarning (2013Q4-2014Q1), transition (2014Q2-2014Q4), and postwarning (2015Q1-2015Q3) period using multivariable regressions.
Results: Among 212,146 women undergoing benign hysterectomy at 511 hospitals, the use of laparoscopic supracervical hysterectomy decreased from 15.1% in 2013Q4 to 6.2% in 2015Q3. The use of laparoscopic supracervical hysterectomy at these 511 hospitals exhibited 4 distinct trajectory patterns: persistent low use (mean risk-adjusted utilization rate of laparoscopic supracervical hysterectomy changed from 2.8% in 2013Q4 to 0.6% in 2015Q3), decreased medium use (17.0% to 6.9%), decreased high use (51.4% to 24.2%), and rapid abandonment (30.5% to 0.8%). In the meantime, use of open abdominal hysterectomy increased by 2.1, 4.1, 7.8, and 11.8 percentage points between the prewarning and postwarning periods in these 4 trajectory groups, respectively. Compared with the prewarning period, the risk of major complications in the postwarning period decreased among patients at "persistent low use" hospitals (adjusted odds ratio, 0.88; 95% confidence interval, 0.81-0.94). In contrast, the risk of major complications increased among patients at "rapid abandonment" hospitals (adjusted odds ratio, 1.48; 95% confidence interval, 1.11-1.98), and the risk of minor complications increased among patients at "decreased high use" hospitals (adjusted odds ratio, 1.31; 95% confidence interval, 1.01-1.72).
Conclusion: Hospitals varied in their use of laparoscopic supracervical hysterectomy after safety warnings about power morcellation. Complication risk increased at hospitals that shifted considerably toward open abdominal hysterectomy.
Keywords: complication; hospital variation; hysterectomy; laparoscopic; power morcellation; trajectory.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.Obstet Gynecol. 2019 Aug;134(2):227-238. doi: 10.1097/AOG.0000000000003375. Obstet Gynecol. 2019. PMID: 31348209
-
Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.JAMA Surg. 2018 Jun 20;153(6):e180141. doi: 10.1001/jamasurg.2018.0141. Epub 2018 Jun 20. JAMA Surg. 2018. PMID: 29641835 Free PMC article.
-
Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.Am J Obstet Gynecol. 2016 Jan;214(1):98.e1-98.e13. doi: 10.1016/j.ajog.2015.08.047. Epub 2015 Aug 24. Am J Obstet Gynecol. 2016. PMID: 26314519
-
Complications in Laparoscopic Supracervical Hysterectomy(LASH), especially the morcellation related.Best Pract Res Clin Obstet Gynaecol. 2016 Aug;35:44-50. doi: 10.1016/j.bpobgyn.2015.11.001. Epub 2015 Nov 14. Best Pract Res Clin Obstet Gynaecol. 2016. PMID: 26694587 Review.
-
[Hysterectomy for benign gynaecological disease: Surgical approach, vaginal suture method and morcellation: Guidelines].J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):1168-82. doi: 10.1016/j.jgyn.2015.09.032. Epub 2015 Oct 31. J Gynecol Obstet Biol Reprod (Paris). 2015. PMID: 26527018 Review. French.
Cited by
-
Defining a Uterine Extraction Score based on a Volume/Access Ratio in Total Hysterectomy: a retrospective cohort study.Facts Views Vis Obgyn. 2024 Mar;16(1):75-81. doi: 10.52054/FVVO.16.1.009. Facts Views Vis Obgyn. 2024. PMID: 38551477 Free PMC article.
-
The Future of Minimal-Access Myoma Surgery with In-Bag Contained Morcellation.J Clin Med. 2023 May 23;12(11):3628. doi: 10.3390/jcm12113628. J Clin Med. 2023. PMID: 37297823 Free PMC article.
-
Safety Warning about Laparoscopic Power Morcellation in Hysterectomy: A Cost-Effectiveness Analysis of National Impact.Womens Health Rep (New Rochelle). 2022 Mar 28;3(1):369-384. doi: 10.1089/whr.2021.0101. eCollection 2022. Womens Health Rep (New Rochelle). 2022. PMID: 35415718 Free PMC article.
-
Operative Complications and Outcomes Comparing Small and Large Uterine Weight in Case of Laparoscopic Hysterectomy for a Benign Indication.Front Surg. 2021 Oct 5;8:755781. doi: 10.3389/fsurg.2021.755781. eCollection 2021. Front Surg. 2021. PMID: 34676242 Free PMC article.
References
-
- National Quality Forum. Measure Evaluation Criteria. http://www.qualityforum.org/Measuring_Performance/Submitting_Standards/M.... Accessed October 27, 2020.
-
- Agency for Healthcare Research and Quality. Quality Indicator Empirical Methods. Rockville, MD. 2019. https://www.qualityindicators.ahrq.gov/Downloads/Resources/Publications/.... Accessed March 9, 2020.
-
- Nagin DS. Group-based modeling of development. Cambridge, MA: Harvard University Press, 2005.
-
- U.S. Food and Drug Administration (FDA). Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. April 17, 2014; http://wayback.archive-it.org/7993/20170722215731/https://www.fda.gov/Me.... Accessed June 15, 2020.
-
- U.S. Food and Drug Administration (FDA). FDA warns against using laparoscopic power morcellators to treat uterine fibroids. November 24, 2014; https://wayback.archive-it.org/7993/20170404182209/https:/www.fda.gov/Me.... Accessed June 9, 2020.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
